We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$12.8B
AUM Growth
+$523M
Cap. Flow
+$168M
Cap. Flow %
1.32%
Top 10 Hldgs %
18.35%
Holding
1,089
New
86
Increased
474
Reduced
397
Closed
48

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$63.4M
2
SNY icon
Sanofi
SNY
+$55.8M
3
ORCL icon
Oracle
ORCL
+$55.7M
4
SJM icon
J.M. Smucker
SJM
+$51.1M
5
ICE icon
Intercontinental Exchange
ICE
+$50.9M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$71.6M
2
CTRA
Coterra Energy
CTRA
+$66.7M
3
BKNG icon
Booking.com
BKNG
+$56.3M
4
COF icon
Capital One
COF
+$53.9M
5
KHC icon
Kraft Heinz
KHC
+$51.3M

Sector Composition

Rank Sector Weight
1 Financials 17.57%
2 Technology 13%
3 Healthcare 10.4%
4 Industrials 9.11%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
1026
Vistance Networks Inc
VISN
$2.65B
$73.3K ﹤0.01%
11,500
-3,800
-25% -$28.8K
CGC
1027
Canopy Growth
CGC
$387M
$70.9K ﹤0.01%
4,048
-10
-0.2% -$237
VVR icon
1028
Invesco Senior Income Trust
VVR
$457M
$55.9K ﹤0.01%
15,200
+2,400
+19% +$9.31K
UUUU icon
1029
Energy Fuels
UUUU
$2.86B
$55.7K ﹤0.01%
10,000
NSL
1030
DELISTED
NUVEEN SENIOR INCM FD
NSL
$47.5K ﹤0.01%
10,300
CIK
1031
Credit Suisse Asset Management Income Fund
CIK
$134M
$37.3K ﹤0.01%
14,500
CELG.RT
1032
Bristol-Myers Squibb Rights
CELG.RT
$191M
$11.8K ﹤0.01%
93,770
SMSI icon
1033
Smith Micro Software
SMSI
$14.5M
$11.6K ﹤0.01%
250
XXII
1034
22nd Century Group
XXII
$1.38M
0
MBIO icon
1035
Mustang Bio
MBIO
$4.32M
$11.1K ﹤0.01%
40
NEXI
1036
DELISTED
NexImmune, Inc. Common Stock
NEXI
$6.84K ﹤0.01%
720
+300
+71% +$3.15K
NBSE
1037
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$5.55K ﹤0.01%
1,500
-525
-26% -$2.42K
BBBY
1038
DELISTED
Bed Bath & Beyond Inc
BBBY
$4.27K ﹤0.01%
+10,000
New +$20.6K
CONXW
1039
DELISTED
CONX Corp. Warrant
CONXW
$2.35K ﹤0.01%
13,000
HOFVW
1040
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$886 ﹤0.01%
+13,333
New +$1.01K
IGR.RT
1041
DELISTED
CBRE Global Real Estate Income Fund Rights (expiring April 6, 2023)
IGR.RT
$524 ﹤0.01%
+16,970
New +$287
ABR icon
1042
Arbor Realty Trust
ABR
$964M
-15,997
Closed -$211K
AMTX icon
1043
Aemetis
AMTX
$106M
-85,450
Closed -$338K
APH icon
1044
Amphenol
APH
$198B
-15,184
Closed -$578K
AXSM icon
1045
Axsome Therapeutics
AXSM
$11.2B
-14,200
Closed -$1.09M
BRKR icon
1046
Bruker
BRKR
$9.57B
-5,065
Closed -$346K
BVS icon
1047
Bioventus
BVS
$892M
-14,700
Closed -$38K
DKNG icon
1048
CALL
DraftKings
DKNG
$11.6B
-35,000
Closed -$399K
DRI icon
1049
Darden Restaurants
DRI
$23.3B
-2,066
Closed -$286K
DSX icon
1050
Diana Shipping
DSX
$302M
-12,536
Closed -$39K

Similar funds

Davenport & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Davenport & Co held 1,089 positions worth $12.8B, up 4.3% from $12.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Davenport & Co's Q1 2023 filing shows 86 new, 474 increased, 397 reduced and 48 closed positions. Its largest new stake was JB Hunt Transport Services: 252,836 shares worth $44.4M. The largest sale was T-Mobile US, an estimated $71.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q1 2023 buy was JB Hunt Transport Services: 252,836 shares worth $44.4M.
  • Davenport & Co added most to Charles Schwab in Q1 2023, an estimated $63.4M increase.
  • Davenport & Co's biggest Q1 2023 reduction was T-Mobile US, cutting an estimated $71.6M.
  • Davenport & Co fully exited TARGETS TRUST XIX % TIME WARNER INC 00/00/2006 in Q1 2023, selling an estimated $7.6M.
  • Davenport & Co's ten largest holdings make up 18% of its $12.8B portfolio in Q1 2023.
  • Davenport & Co opened 86 new positions and closed 48 in Q1 2023.
  • Davenport & Co's portfolio value rose 4.3% quarter-over-quarter to $12.8B.

Based on Davenport & Co's 13F filing for Q1 2023, filed 27 Apr 2023.